PTC Therapeutics PTCT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's operating lease liabilities (current)?
- PTC Therapeutics (PTCT) reported operating lease liabilities (current) of $12.08M in Q1 2026.
- How has PTC Therapeutics's operating lease liabilities (current) changed year-over-year?
- PTC Therapeutics's operating lease liabilities (current) increased by 5.4% year-over-year, from $11.46M to $12.08M.
- What is the long-term trend for PTC Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), PTC Therapeutics's operating lease liabilities (current) has grown at a 10.8% compound annual growth rate (CAGR), from $7.47M to $12.48M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.